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CC2D2A, Encoding A Coiled-Coil
and C2 Domain Protein, Causes Autosomal-Recessive
Mental Retardation with Retinitis Pigmentosa
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Autosomal-recessive inheritance is believed to be relatively common in mental retardation (MR), although only four genes for nonsyn-
dromic autosomal-recessive mental retardation (ARMR) have been reported. In this study, we ascertained a consanguineous Pakistani
family with ARMR in four living individuals from three branches of the family, plus an additional affected individual later identiﬁed
as a phenocopy. Retinitis pigmentosa was present in affected individuals, but no other features suggestive of a syndromic form of MR
were found. We used Affymetrix 500K microarrays to perform homozygosity mapping and identiﬁed a homozygous and haploidentical
region of 11.2 Mb on chromosome 4p15.33-p15.2. Linkage analysis across this region produced a maximum two-point LOD score of
3.59. We sequenced genes within the critical region and identiﬁed a homozygous splice-site mutation segregating in the family, within
a coiled-coil and C2 domain-containing gene, CC2D2A. This mutation leads to the skipping of exon 19, resulting in a frameshift and
a truncated protein lacking the C2 domain. Conservation analysis for CC2D2A suggests a functional domain near the C terminus as
well as the C2 domain. Preliminary functional studies of CC2D2A suggest a possible role in Ca2þ-dependent signal transduction. Iden-
tifying the function of CC2D2A, and a possible common pathway with CC2D1A, in correct neuronal development and functioningmay
help identify possible therapeutic targets for MR.Mental retardation (MR) or developmental delay is a het-
erogeneous group of disorders that are deﬁned by deﬁcits
in cognitive and adaptive development. The prevalence
of MR is commonly given as 1%–3% of the population,1
with a higher proportion of males to females affected
(1.4:1).2 MR is subclassiﬁed according to intelligence quo-
tient (IQ) as mild MR in the IQ range 50–55 to 70, moder-
ate MR as 35–40 to 50–55, severe MR as 20–25 to 35–40,
and profound MR as below 20–25.3 Understanding the
etiological basis of MR in affected individuals is important
because it may provide diagnostic clues for possible comor-
bid features (e.g., scoliosis in Rett syndrome), as well as pro-
viding information for genetic counseling, or may help in
identifying a treatable condition such as phenylketon-
uria.4 In addition, understanding the cause of MR may
help families to cope with an affected child and may
help them gain access to support infrastructure.
Genetic factors are involved in the etiology of approxi-
mately two-thirds of MR cases.5 In inherited forms of
MR, X-linkage or autosomal-recessive inheritance patterns
are the most plausible because procreation from affected
individuals is not common. To date, more than 60 loci
have been reported for X-linked MR;6 however, the molec-
ular genetic basis for ARMR is still poorly understood.
Although autosomal-recessive inheritance is estimated to
be involved in nearly a quarter of all individuals with non-
syndromic MR (reviewed in Basel-Vanagaite et al.7), onlyThe Amfour autosomal genes, PRSS12 on 4q26 (neurotrypsin
[MIM #606709]), CC2D1A on 19p13.12 [MIM #610055],
CRBN on 3p26 (cereblon [MIM #609262]), and very
recently GRIK2 on 6q16.3 (ionotropic glutamate receptor
6 [MIM #138244]) have been reported so far to cause non-
syndromic ARMR (NS-ARMR).8–11 However, only a very
few families or unrelated individuals with ARMR have
been conﬁrmed for each of these genes (PRSS12, n ¼ 2;
CRBN, n ¼ 1; CC2D1A, n ¼ 9; GRIK2, n ¼ 1). The most
recent of these genes,GRIK2, was discovered at one of eight
loci for NS-ARMR recently mapped by homozygosity map-
ping in 78 consanguineous Iranian families. However, no
disease gene or mutation has yet been reported for the
other seven loci.12 Another recently published study has
mapped a new locus for NS-ARMR to 1p21.1-p13.3.13 Ret-
initis pigmentosa (RP;MIM268000) describes a progressive
constriction of the visual ﬁelds, nyctalopia, and fundus-as-
sociated changes. To date, no genes have been reported for
otherwise nonsyndromic MR associated with RP, although
MR and RP are present together in some syndromic forms
of MR, such as several forms of Bardet-Biedl syndrome
(MIM 209900).
We ascertained an ARMR family from a farming commu-
nity in the district of Mianwali, Punjab province, Pakistan.
The pedigree structure indicates a high degree of consan-
guinity (Figure 1), with ﬁrst-cousin marriages among the
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Figure 1. Pedigree Showing Three Branches of the Family from Mianwali District, Punjab Province, Pakistan
Filled symbols indicate individuals affected with mental retardation. The quarter-filled symbol, highlighted within a red box, indicates the
patient with mental retardation but subsequently determined to have tetrasomy X.MR among the male and female offspring in three
branches of the family. Institutional research ethics
approval was obtained, and written informed consent
was obtained for all participants in the study. Height,
weight, and occipitofrontal circumference were all within
the normal range. The older three patients, who are either
adult or adolescent, have retinitis pigmentosa and astigma-
tism; the adult male patient also has early cataract. The
youngest patient (currently age 3 years) does not have ret-
initis pigmentosa but does have astigmatism. All the
patients have nystagmus. RP was not present in other
members of the family. There are two difﬁculties in assess-
ment of level of MR in these individuals: lack of measuring
instruments with normative values for the local popula-
tion and problems with administration of the instruments
because of visual impairment. The patients and a number
of relatives were assessed by a consultant in psychiatry,
M. Ayub, who specializes in learning disability/MR and
trained both in Pakistan and the UK. The patients and
relatives were interviewed so that information could be
gathered about development in different domains (motor,
language, cognitive, social, and emotional), current level
of social functioning, and help and support required for ac-
tivities of daily living. All this information was discussed
with a clinical psychologist practicing in Lahore with
over 20 years of experience of working with people with
MR in that culture. They reached consensus diagnosis for
all the affected individuals (WHO 1994). A diagnosis of
mild to moderate MR was reached for all the affected indi-
viduals with ICD 10 criteria. Physical and neurological1012 The American Journal of Human Genetics 82, 1011–1018, Aprassessment was performed by a consultant neurologist
(M. Azam) on the youngest female affected (at 20 months)
as well as the male affected (at 27 years old). There were no
focal neurological abnormal signs. For both, there were no
dysmorphic features, no hepatosplenomegaly, no heart
murmur, and no skin abnormalities; however, vision was
impaired for the male. Development was globally delayed
for the female infant. Structural MRI of the brain was per-
formed for these two affected individuals; the results were
generally normal, although with some suggestion of mild
cerebellar atrophy in the male affected individual. Photo-
graphs of all affected individuals were assessed for dysmor-
phic features by an experienced clinical geneticist;
however, no unusual facial features were apparent.
Blood samples were collected from ﬁve affected and 12
unaffected members of the family. Genomic DNA was
extracted by standard methods. Lymphoblast cell lines
were also successfully established for several family mem-
bers (Figure 1, individuals 23, 24, 25, 26, 37, and 50),
RNA was extracted, and ﬁrst-strand cDNA was synthesized
by standard methods. DNA from the ﬁve affected and one
unaffected individuals were analyzed with the Affymetrix
GeneChip Mapping 500K array NspI chip, which allowed
us to genotype ~260,000 SNPs. The arrays were scanned
with a GeneChip Scanner, and the data were processed
with GeneChip Operating Software (GCOS) andGeneChip
Genotyping Analysis Software (GTYPE) software (ver.
3.0.2) for generation of SNP allele calls. Analysis revealed
a common ~11.2 Mb homozygous and haploidentical re-
gion on the short arm of chromosome 4 (4p15.2-p15.33;il 2008
Figure 2) in four affected individuals but not in the normal
individual or the ﬁfth affected individual. This was the
only large (>0.5 Mb) homozygous region present in four
out of ﬁve affected individuals, and no such regions were
present in all ﬁve. We conﬁrmed the boundaries of the
11.2 Mb critical region containing ~39 genes (UCSC
Genome Browser, March 2006) by sequencing the ﬂanking
SNPs, rs2191685 and rs7664104 (at 14.001 and 25.203 Mb
from the p telomere, respectively), in order to conﬁrm their
heterozygous status.
Because homozygosity mapping did not reveal any com-
mon region in all ﬁve affected individuals, we further
hypothesized that there might be a chromosomal deletion
or duplication segregating with phenotype. Copy-number
variations (CNVs) were inferred by comparative analysis of
hybridization intensities with dChip analyzer.14–16 After
normalization, we used the hidden Markov model
Figure 2. Ideogrammatic Representa-
tion of the Mutation Region on 4p15.33
(A) Position of the 11.2 Mb common homo-
zygous stretch on 4p15. and the organiza-
tion of various known genes within this
region.
(B) The intron 19 donor splice-site muta-
tion sequence, with wild-type, followed
by carrier (heterozygote) sequence and
the homozygous mutation from affected
individuals.
(C) The genomic organization of CC2D2A
and the consequence of the mutation,
namely the splicing out of exon 19, which
results in a shift of reading frame leading
to 13 nonsense amino acids followed by
a stop codon, thus prematurely truncating
the protein at this point. Sequence analy-
sis was performed with BigDye Terminator
v3.1 Cycle Sequencing (Applied Biosys-
tems).
(HMM) to infer the DNA copy num-
ber. Interestingly, copy-number anal-
ysis indicated a gain across the entire
X chromosome in the ﬁfth affected
individual, who did not share the
4p15.3 haplotype with the other
four affected members of the family.
Subsequent cytogenetic analysis indi-
cated the karyotype 48,XXXX. This
rare tetrasomy is almost always associ-
ated with mental retardation, with an
IQ range of 30 to 75 (mean IQ of
60),17 and thus suggests that this fe-
male is a phenocopy. No other CNVs
of interest were identiﬁed among the
affected individuals.
We conﬁrmed linkage to the locus
on chromosome 4p15.33-p15.2 by
genotyping 17members of the family with the 12microsa-
tellite markers across the 4p region (Table 1) and using an
ABI 3730xl DNA analyzer and Genemapper software (Ap-
plied Biosystems). Parametric linkage analysis was per-
formed with MLINK (2-point) and LINKMAP (shifting
three-point).18,19 Linkage analysis revealed a maximum
two-point logarithmofodds (LOD) scoreof3.59 (theta¼0.0)
at marker D4S419 (Table 1), whereas a maximum LOD
score of 4.1 was obtained by multipoint analysis. A shared
disease haplotype was identiﬁed for the microsatellite
markers D4S3048, D4S1525, D4S419, D4S1546, and
D4S425 (Figure 3).
The 11.2 Mb critical region, as deﬁned by the homozy-
gosity data, contains ~39 annotated genes (UCSC 2006).
First, we excluded QDPR, the gene for phenylketonuria
type 2 (PKU2; MIM þ262630), which lies within the criti-
cal region, by sequence analysis and biochemical analysisThe American Journal of Human Genetics 82, 1011–1018, April 2008 1013
Table 1. Two-Point Linkage Analysis of Microsatellite Markers across the 4p Region
Marker Physical Position (Mb)
Genetic Distance
Female (cM)
Genetic Distance
Male (cM)
Sex Averaged Genetic
Distance (cM) LOD
D4S1599 10.404 25.5 20.9 23.2 0.98979
D4S3036 11.728 26.5 22.3 24.4 0.662288
D4S403 13.259 28.7 23.4 26.05 1.479108
D4S3048 15.516 29.7 28.8 29.25 2.304191
D4S1525 16.092 29.7 29.9 29.8 2.208764
D4S419 18.357 36.2 30.9 33.55 3.597317
D4S1546 20.275 37.3 33.1 35.2 2.007724
D4S425 23.165 38.3 34.1 36.2 2.822141
D4S391 27.121 46.9 40.6 43.75 5.677216
D4S2408 30.813 50.1 41.9 46 1.635551
D4S405 39.947 69.4 44.8 57.1 1000
D4S1592 57.276 91.6 48 69.8 1000
We assumed an autosomal-recessive model with complete penetrance and a disease allele frequency of 0.0001. We assumed that marker-allele frequencies
were equal. Markers shaded gray are within the homozygous critical region shared by the four affected individuals. Positive LOD scores are highlighted in
italics.of patients’ blood. We then sequenced all other known
genes in the region and identiﬁed a splice-donor-site muta-
tion (IVS19þ1:G/C) in exon 19 of a gene, coiled-coil and
C2 domain 2A, CC2D2A (Figure 2). This homozygous mu-
tation segregates with the phenotype in the Mianwali fam-
ily. CC2D2A (NM_001080522; also known as KIAA1345)
has an mRNA ~5 kb in length and is found in at least 13
different isoforms with up to 37 exons spanning ~131.5 kb
of genomic DNA (from 15,080,760–15,212,278 bp; UCSC
March 2006) on 4p15.33. The CC2D2A protein contains
up to 1620 amino acids (depending on exon usage), and
a C2 domain is predicted from residue 1042-1202. RT-
PCR ampliﬁcation followed by sequence analysis withlymphoblast-derived cDNA from the affected individuals
indicated that the splice mutation results in the skipping
of exon 19. The splicing of exon 18 to exon 20 causes
a frameshift, resulting in the addition of 13 nonsense
amino acids added (p.V728EfsX741; NP_001073991) be-
yond exon 18 before a premature stop codon truncates
the protein after amino acid 740, thus abolishing the C2
domain (Figure 2). This mutation was not present in 460
chromosomes of healthy Pakistani controls.
RT-PCR analysis indicates that CC2D2A is expressed in
many adult tissues (Figure 4). In a panel of cDNAs from
12 tissues, expression was detected in each tissue, albeit
at varying levels, with maximum expression seen in theFigure 3. Haplotype Analysis
Markers are shown in red, and haplotypes
within a red box indicate the disease hap-
lotype shared between affected individuals
(homozygous) and carriers (heterozygous).
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Figure 4. Tissue Transcription Analysis
of CC2D2A
RT-PCR expression analysis with a multiple-
tissue panel of normalized first-strand
cDNA (Clontech) for CC2DA (top) and
housekeeping gene G3PDH, which was run
as a control (bottom). For RT-PCR amplifi-
cation, we used a forward primer from
exon 18 (50-ACAGTCAGTCGGCCACTAGG-30)
and a reverse primer from exon 25 (50-
GTTCTGCCAGCTTGAAAAGG-30) with PCR
product size of 963 bp. A 100 bp size ladder
is shown to the left.prostate, pancreas, kidney, lung, and liver, and lower
expression in the spleen, small intestine, colon, skeletal
muscle, ovary, thymus, and heart. Brain expression with
human fetal brain Marathon Ready cDNA (Clontech) was
also strong (not shown). To study cellular localization of
the CC2D2A protein, we overexpressed a CC2D2A-GFP
fusion protein in Cos7 cells. Localization appeared to be
almost exclusively cytoplasmic, despite the predicted pres-
ence of potential nuclear localization signals (data not
shown).
Genomic organization of CC2D2A on 4p15.33 is shown
in Figure 2. Analysis of the sequence at and around the
CC2D2A gene with the PromoterInspector program indi-
cated the presence of a putative promoter sequence of
773 bp from 15,080,088–15,080,860 bp (from the 4p telo-
mere; UCSCMarch 2006). Analysis of the protein sequence
using SMART indicated the presence of a C2 domain from
residue 1042 to 1202 (in the 1620 amino acid isoform). The
C2 domain, also known as protein kinase C conserved
region 2 (CalB), is a Ca2þ-dependent membrane-targeting
module present in many proteins involved in membrane
trafﬁcking or signal transduction. Transmembrane (TM)
prediction with TMpred suggested two possibilities: either
one strong TM helix (from residues 1278 to 1297) or no
clear TM domains. Coiled-coil analysis with COILSv.2.1
predicted three stretches of the protein with >90% proba-
bility of coiled-coil structure: amino acid residues 442–463,
472–492, and 533–580 (with a 21-residue window). SOSUI
predicts the protein to be soluble, with average hydropho-
bicity of 0.655. Secondary structure is predicted to be
mainly alpha helix and random coil, with some extended
strand (network protein sequence analysis). No signal pep-
tides were detected. In addition, initial analysis indicates
that CC2D2A appears to have a number of potential
CaMKII recognition sites (9 RXXS/T and 3 S/TXD sites), as
well as numerous putative PKC phosphorylation sites. Two
putative nuclear localization signals were also detected
with the PredictProtein suite (QRAKKKKRK at residue
587 and RPRRK at 1021). Protein-alignment analysis indi-
cates that CC2D2B has no homology with either CC2D1A
or CC2D1B. There is 34% homology between CC2D2A
and CC2D2B (NM_001001732; 10q23), but only toward
the C-terminal end (residues 1250–1620; Figure 5B) of
CC2D2A. CC2D2B has neither coiled-coil nor C2 domains.The AmComparative analysis of the protein sequence with
ClustalW across 18 species shows a high degree of conser-
vation across vertebrate evolution (Figure 5). The human
sequence is 99.4% identical to that of chimp, 96.9% iden-
tical to that of rhesus monkey, 88.8% identical to that of
horse, 84.8% identical to that of mouse and rat, 75.7%
identical to that of opossum, 70.7% identical to that of
chicken, 60% identical to that of Xenopus, 59.6% identical
to that of zebraﬁsh, and 44.7% identical to that of sea
urchin. The human protein is 21.6% identical to C. elegans
protein K07G5.3 (NP_492026) and 29.9% identical to Dro-
sophila protein CG18631 (NP_611230), with the strongest
overlap and homology occurring toward the C-terminal
end (from amino acid 1301 in human, 894 in C. elegans,
and 200 in Drosophila, to the carboxyl terminus), suggest-
ing conserved functionality to this region in addition to
the C2 domain. The WormBase information on the C. ele-
gans orthologous gene K07G5.3 indicates that it is ex-
pressed in the nervous system, including head and tail
neurons (as well as other unidentiﬁed cells in the head
and tail) during both adult and larval stages. Knockdown
of K07G5.3 through RNAi was nonlethal.
We studied rates of evolutionary change for CC2D2A
gene and for domain-encoding regions within CC2D2A,
with pairwise comparisons between more closely related
species. We calculated Ka and Ks values20–22 to examine
the level of amino acid changing and silent nucleotide
divergence between gene pairs. Ka is the number of nonsy-
nonymous substitutions per nonsynonymous site, and Ks
is the number of synonymous substitutions per synony-
mous site. Comparing the Ka/Ks ratio can provide insight
into the evolutionary proﬁle of a gene sequence because
a Ka/Ks ratio signiﬁcantly greater than 1.0 is strong evi-
dence of positive selection, whereas a Ka/Ks ratio of less
than 0.45 indicates negative selection. Interestingly, the
C2 domain appears to have a different evolutionary proﬁle
in the primate lineage than the rodent lineage. In the pri-
mates, the C2 domain has higher Ka and Ks than either the
full-length sequence (Table 2, rows 1–3) or the regions
ﬂanking the C2 domain, FR1 and FR2 (Table 3, upper sec-
tion). In the rodent lineage, however, based on Ka values,
the C2 domain is more conserved at the amino acid level
than the full-length sequence (Table 2, row 6) or at FR1
and FR2 (Table 3, upper section). This suggests that theerican Journal of Human Genetics 82, 1011–1018, April 2008 1015
Figure 5. Comparative Protein Sequence Analysis of CC2D2A
Boxshade alignments for (A) a section of the C2 domain (residues 1099 to 1202 of the human protein) and (B) a section of the C-terminal
region (1280–1463). A selection of sequences from 11 representative species (out of 18 studied) across the evolutionary spectrum are
shown. Alignment with the C-terminal region of the human paralogue, CC2D2B, is also shown; however, no homology was detected with
the C2 region. The upstream half of the C2 region is not shown because sections of this region are not present in some lower-order ver-
tebrates and nonvertebrates. Also, only a portion of the C-terminal region is shown, for the sake of succinctness. Residues that were
conserved across all 18 species analyzed (including those not included in the figure: chimp, horse, cow, rat, tetraodon, zebrafish, and
Drosophila) are marked with an asterisk. Accession numbers for sequences used are as follows in parentheses: chimpanzee
(XM_526530), rhesus monkey (XM_001118936), horse (XM_001500638), cow (UPI0000F333EB), dog (UPI0000EB4478), mouse
(NM_172274), rat (XM_001055728), opossum (XM_001369737), chicken (XM_420777), Xenopus (BC077972), zebrafish (XM_693709),
fugu (NEWSINFRUT00000150241), tetraodon (GSTENT00032796001), sea urchin (XM_775975), fruitfly (NM_137386), mosquito
(XM_001658220), and nematode (NM_059625).C2 domain in the primate lineage may be more permissive
of amino-acid-changing substitutions than the ortholo-
gous region in the rodent lineage. This may suggest a
primate-speciﬁc role for this subdomain in neuronal devel-
opment because affected individuals in this study express
Table 2. Pairwise Analysis of Synonymous versus
Nonsynonymous Nucleotide Substitutions for the Full-Length
CC2D2A Sequence and for the C2 Domain
Species
cDNA Full-Length C2 Domain
Ka Ks Ka/Ks Ka Ks Ka/Ks
Human-Chimp 0.0029 0.0074 0.3937 0.0087 0.0184 0.4755
Human-Rhesus 0.0155 0.0558 0.2775 0.0182 0.0732 0.2493
Chimp-Rhesus 0.0155 0.0521 0.2983 0.0221 0.0675 0.3272
Human-Mouse 0.0813 0.5117 0.1588 0.0443 0.5567 0.0796
Human-Rat 0.0814 0.5249 0.1551 0.0503 0.6294 0.0799
Mouse-Rat 0.0258 0.1689 0.1527 0.0056 0.2466 0.0227
The Ka is the number of nonsynonymous substitutions per nonsynonymous
site, and the Ks is the number of synonymous substitutions per synonymous
site.1016 The American Journal of Human Genetics 82, 1011–1018, Apra truncated CC2D2A lacking the C2 domain. Additional
mapping of point mutations in this region may help to
conﬁrm this hypothesis. For the C-terminal region, in all
pairwise comparisons, the Ka/Ks ratios were signiﬁcantly
lower than for the N terminal region (Table 3, lower sec-
tion), providing additional evidence that the C-terminal
region is also well conserved across species.
CC2D2A lies on 4p15.3 within a region involved in
proximal interstitial deletions (proximal to theWolf-Hirsch-
hornsyndrome(WHS;MIM#194190)andPitt-Rogers-Dank
syndrome (PRDS; MIM #262350) deletion regions. To date,
more than 20 cases have been reported, and the clinical fea-
tures include facies and other dysmorphologcal features as
well as varying degrees of mental retardation (discussed in
Tonk et al.23); however, RP is not a known feature.
CC2D1A, one of the four previously identiﬁed ARMR
genes,8 also encodes a single C2 domain toward the C-ter-
minal end of the protein in addition to coiled-coil regions,
and thus we speculate that these two proteins, CC2D1A
and CC2D2A, may have similar functions and may be
components of the same or parallel pathways that areil 2008
important components for neuronal development, disrup-
tion of which leads to developmental delay. CC2D1A is
also known as Freud-1 (ﬁve prime repressor under dual
repression binding protein-1). A deletion mutation was
identiﬁed that spans 3.6 kb, deleting exons 14 to 16,
thereby resulting in a truncated protein lacking the C2
domain. The mouse homolog of CC2D1A/Freud-1 was ini-
tially identiﬁed as a transcription factor involved in the
negative regulation of the serotonin 1A receptor gene
(HTR1A).24,25 Serotonin 1A receptors are expressed in the
cortex, limbic system, and hypothalamus and are associ-
ated with depression, anxiety, sexual activity, stress re-
sponse, and learning.26 CC2D1A/Freud-1 is colocalized
with HTR1A receptors in both presynaptic and postsynap-
tic serotonin system neurons.25 Recent studies have shown
that CC2D1A/Freud-1 also regulates transcription of the
dopamine receptor DRD2.27
Freud-1 is highly conserved through evolution, with
orthologs in invertebrate species such as C. elegans.
Freud-1 contains four DM14 domains (D. melanogaster
14; unknown function), one helix-loop-helix (HLH)
domain, one C2 domain, a proline-rich domain believed
to be involved in protein binding,28 coiled-coil oligomeri-
zation motifs,29 putative phosphorylation sites for protein
kinases A and C, and two calcium calmodulin-dependent
protein kinase (CaMK) II/IV sites. Our preliminary exami-
nation of CC2D2A protein indicates the presence of the
coiled-coil domains and the C2 domain, as well as PKC
and CaMKII sites. However, homology analysis indicates
that this protein is not a member of the Freud protein fam-
ily. A recent study aimed at screening the human proteome
for calmodulin (CaM) protein binding partners with the
Table 3. Analysis of Rates of Evolutionary Change for CC2D2A
Species
FR1 FR2
Ka Ks Ka/Ks Ka Ks Ka/Ks
Human-Chimp 0.0000 0.0000 n/a 0.0031 0.0000 n/a
Human-Rhesus 0.0060 0.0487 0.1232 0.0031 0.0251 0.1235
Chimp-Rhesus 0.0060 0.0487 0.1232 0.0061 0.0252 0.2421
Human-Mouse 0.0500 0.3178 0.1573 0.0533 0.5594 0.0953
Human-Rat 0.0479 0.2821 0.1698 0.0485 0.5551 0.0874
Mouse-Rat 0.0141 0.0925 0.1524 0.0103 0.1907 0.0540
Species
N Terminal C-Terminal
Ka Ks Ka/Ks Ka Ks Ka/Ks
Human-Chimp 0.0027 0.0027 0.9853 0.0011 0.0000 na
Human-Rhesus 0.0254 0.0515 0.4940 0.0038 0.0275 0.1384
Chimp-Rhesus 0.0254 0.0485 0.5245 0.0027 0.0275 0.0989
Human-Mouse 0.1803 0.4834 0.3730 0.0486 0.4130 0.1176
Human-Rat 0.1847 0.5643 0.3273 0.0439 0.3870 0.1134
Mouse-Rat 0.0608 0.1870 0.3254 0.0099 0.1985 0.0499
Pairwise comparison of synonymous versus nonsynonymous nucleotide
substitutions for flanking regions FR1 and FR2 500 bp upstream and down-
stream of C2, respectively (upper section), and for the N-terminal region
(the first 1115 nucleotides at the N terminus in human) and C-terminal
region (encompassing the last 1113 nucleotides of the coding sequence
in the human) (lower section).The AmmRNA display technique has identiﬁed CC2D2A as a
potential CaM-binding protein.30 CaM is the most
widespread and well studied of Ca2þ sensors in eukaryotic
cells. This adds further support to a role for CC2D2A in
Ca2þ-regulated signaling pathways.
Given the various commonalities between CC2D1A/
Freud-1 and CC2D2A in terms of protein structure and
the phenotypic consequences of truncation mutation, we
hypothesize that they may function in similar pathways
or mechanisms, i.e., transcriptional regulation and signal-
ing, which may be crucial for correct neuronal develop-
ment. Study of a commonpathwaymayhelp identify other
genes involved in NSMR (also possibly in RP), as well as
potential therapeutic targets for developmental delay.
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